BioCentury | Apr 17, 2019
Company News

Management tracks: RegenxBio, Verrica, Reagan-Udall Foundation

...permanent successor. The foundation creates public-private partnerships to advance regulatory science that supports FDA. The Lustgarten Foundation...
...Cancer Research (AACR). The Lustgarten Foundation is a private funder of pancreatic cancer research. Hongjiang Li, Staff Writer Lustgarten Foundation RegenxBio...
BioCentury | Nov 10, 2018
Preclinical News

June highlights shorter CAR T culture times at SITC

...by Stand Up To Cancer. June's lab has funding from SU2C, in partnership with the Lustgarten Foundation...
...therapy (see "Carl June, NIBR Teams Document CAR T Resistance" ). Karen Tkach Tuzman CD19 CAR T cells Lustgarten Foundation Novartis...
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...in grants awarded in collaboration with the LUNGevity Foundation, the American Lung Association and the Lustgarten Foundation...
...partners to develop funding calls and oversee project selection and management. In partnership with the Lustgarten Foundation...
...Hopkins University, Baltimore, Md. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. LUNGevity Foundation, Chicago, Ill. Lustgarten Foundation...
BioCentury | Feb 2, 2018
Company News

Microsoft, SU2C seek to decrypt immune responses in cancer

...Medicine, Dana-Farber Cancer Institute, Stanford University, University of Pennsylvania and Massachusetts Institute of Technology. Additionally, Lustgarten Foundation...
BioCentury | Jan 30, 2018
Company News

Microsoft, SU2C seek to decrypt immune responses in cancer

...Medicine, Dana-Farber Cancer Institute, Stanford University, University of Pennsylvania and Massachusetts Institute of Technology. Additionally, Lustgarten Foundation...
BioCentury | Jan 27, 2017
Company News

Caris, Lustgarten deal

...Life Sciences Inc. , Irving, Texas Lustgarten Foundation, Bethpage, New York Business: Cancer Shannon Lehnbeuter Keytruda MK-3475 pembrolizumab Caris Life Sciences Inc. Lustgarten Foundation...
BioCentury | Jun 12, 2014
Targets & Mechanisms

Stromal uncertainties in pancreatic cancer

...as depletion of stromal fibroblasts or hedgehog inhibition," said Tuveson. He is director of the Lustgarten Foundation...
...Francisco, Calif. Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Cambridge, Mass. Lustgarten Foundation...
Items per page:
1 - 7 of 7
BioCentury | Apr 17, 2019
Company News

Management tracks: RegenxBio, Verrica, Reagan-Udall Foundation

...permanent successor. The foundation creates public-private partnerships to advance regulatory science that supports FDA. The Lustgarten Foundation...
...Cancer Research (AACR). The Lustgarten Foundation is a private funder of pancreatic cancer research. Hongjiang Li, Staff Writer Lustgarten Foundation RegenxBio...
BioCentury | Nov 10, 2018
Preclinical News

June highlights shorter CAR T culture times at SITC

...by Stand Up To Cancer. June's lab has funding from SU2C, in partnership with the Lustgarten Foundation...
...therapy (see "Carl June, NIBR Teams Document CAR T Resistance" ). Karen Tkach Tuzman CD19 CAR T cells Lustgarten Foundation Novartis...
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...in grants awarded in collaboration with the LUNGevity Foundation, the American Lung Association and the Lustgarten Foundation...
...partners to develop funding calls and oversee project selection and management. In partnership with the Lustgarten Foundation...
...Hopkins University, Baltimore, Md. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. LUNGevity Foundation, Chicago, Ill. Lustgarten Foundation...
BioCentury | Feb 2, 2018
Company News

Microsoft, SU2C seek to decrypt immune responses in cancer

...Medicine, Dana-Farber Cancer Institute, Stanford University, University of Pennsylvania and Massachusetts Institute of Technology. Additionally, Lustgarten Foundation...
BioCentury | Jan 30, 2018
Company News

Microsoft, SU2C seek to decrypt immune responses in cancer

...Medicine, Dana-Farber Cancer Institute, Stanford University, University of Pennsylvania and Massachusetts Institute of Technology. Additionally, Lustgarten Foundation...
BioCentury | Jan 27, 2017
Company News

Caris, Lustgarten deal

...Life Sciences Inc. , Irving, Texas Lustgarten Foundation, Bethpage, New York Business: Cancer Shannon Lehnbeuter Keytruda MK-3475 pembrolizumab Caris Life Sciences Inc. Lustgarten Foundation...
BioCentury | Jun 12, 2014
Targets & Mechanisms

Stromal uncertainties in pancreatic cancer

...as depletion of stromal fibroblasts or hedgehog inhibition," said Tuveson. He is director of the Lustgarten Foundation...
...Francisco, Calif. Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Cambridge, Mass. Lustgarten Foundation...
Items per page:
1 - 7 of 7